TriSalus Life Sciences, Inc. (TLSI): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$14.96M

Year ended 2025-12-31

2022-12-31 R&D Expense (USD) 2025-12-31

Period ended	R&D Expense	Change YoY	Source filing
2025-12-31	$14.96M	-15.4%	2026-03-05, From 2025-01-01
2024-12-31	$17.69M	-40.7%	2026-03-05, From 2024-01-01
2023-12-31	$29.84M	n/c	2025-05-30, From 2023-01-01
2022-12-31	$21.36M	n/a	2024-04-11, From 2022-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	R&D Expense	Change YoY
TriSalus Life Sciences, Inc. (TLSI)	2025-12-31	$14.96M	-15.4%
SANUWAVE Health, Inc. (SNWV)	2025-12-31	$1.35M	+101.0%
Shoulder Innovations, Inc. (SI)	2025-12-31	$7.73M	+72.2%
SS Innovations International, Inc. (SSII)	2025-12-31	$3.69M	+47.9%
KORU Medical Systems, Inc. (KRMD)	2025-12-31	$4.39M	-16.6%
Carlsmed, Inc. (CARL)	2025-12-31	$17.02M	+19.0%
Interpace Biosciences, Inc. (IDXG)	2025-12-31	$642.0K	-5.0%
Apyx Medical Corp (APYX)	2025-12-31	$3.37M	-33.6%
Utah Medical Products Inc (UTMD)	2025-12-31	$668.0K	-17.8%

Compare TLSI, SNWV, SI, SSII side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗